Close
Login
WHO Login
0
Selected
Invert selection
Deselect all
Deselect all
Click here to refresh results
Click here to refresh results
Go to Login page
Hide details
Related Assets
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 16:18:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:32:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:45:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 09:54:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:57:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/12/2022 11:11:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 11:39:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/12/2022 11:09:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:49:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:32:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:54:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:10:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:52:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 10:36:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:05:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/12/2022 11:23:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 11:23:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 09:51:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:37:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 13:38:00
Conceptually Similar Documents
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:32:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 08:02:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 08:10:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 08:04:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 09:43:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:55:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:42:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:46:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:58:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:37:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:43:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:32:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:49:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:45:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:39:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:41:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 07:29:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 09:58:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/11/2022 10:00:00
South Africa: mRNA vaccine technology transfer hub, February 2022
02/10/2022 10:31:00
Similar tones
View images with similar tones
Get link
Copy Unique ID
Restrictions
If you want to request more than one asset, you can enter all Reference IDs in a single permission request form.
Download request for external user
Reference ID
U278UXC
Headline
South Africa: mRNA vaccine technology transfer hub, February 2022
Description
On 11 February 2022, a laboratory technician at work at Afrigen in Cape Town, South Africa.
Announced on 21 June 2021, the objective of the technology transfer hub is to build capacity in low- and middle-income countries to produce mRNA vaccines through a centre of excellence and training (the mRNA vaccine technology hub). The hub is located at Afrigen, Cape Town, South Africa, and will work with a network of technology recipients (spokes) in low- and middle-income countries.Â
The South African hub comprises Afrigen Biologics, the South African Medical Research Council (SAMRC) and Biovac, a South African vaccine producer. Within this consortium, Afrigen is the entity mandated to establish mRNA vaccine production technology, SAMRC is providing the research and Biovac is the first manufacturing spoke.Â
The initiative is supported by WHO, the Medicines Patent Pool and the Act-Accelerator/COVAX.
Related
https://www.who.int/initiatives/the-mrna-vaccine-technology-transfer-hub
Asset date
02/11/2022
Country, area, WHO office
South Africa
City
Cape Town
State/Province
Western Cape
Location
Afrigen
WHO Region
AFRO
Copyright
© Medicines Patent Pool / Rodger Bosch
Consent
No
File size
4.00 MB
Visibility class:
Public
Administered By
HQ Records and Archives
Usage & views counts
Usage (3) Views (53)